Home LiteratureArticle Details
PMID: 2522999 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins.

Journal of virology ·Vol. 63 ·No. 5 ·1989-05-00 ·Pages 2270-7

Riviere Y, Tanneau-Salvadori F, Regnault A, Lopez O, Sansonetti P, Guy B, Kieny MP, Fournel JJ, Montagnier L

Abstract

By using target cells that expressed isolated env, gag, p27nef, or p23vif molecules introduced by recombinant vaccinia viruses containing genes encoding these polypeptides, it was possible to identify env, gag, p27nef, and p23vif as cytolytic target antigens for freshly isolated blood cells from human immunodeficiency virus 1 (HIV-1) seropositive patients. Most of the patients tested (95%) manifested a specific cytotoxic activity against vaccinia virus-env-infected target cells. The env-specific cytotoxic activity was not restricted by the major histocompatibility complex and was not mediated by T lymphocytes, as shown by the absence of blocking effect with an anti-CD3 monoclonal antibody and by the inefficiency of CD3+, CD8+, or CD4+ and CD8+ depletion to reduce the cytotoxic activity against the env-expressing target cells. In the same conditions, the cytotoxic activity specific for gag was abrogated and gag major histocompatibility complex-restricted cytotoxic T lymphocytes were detected in 85% of the subjects tested. Therefore, in a HIV-1 seropositive subject, distinct types of effector cells mediate the lysis of target cells expressing gag and env proteins.

MeSH Terms
Antibodies, Monoclonal Antigens, Differentiation, T-Lymphocyte/immunology CD3 Complex CD8 Antigens Cytotoxicity, Immunologic Gene Products, gag HIV Seropositivity/immunology Humans Immunity, Cellular In Vitro Techniques Major Histocompatibility Complex Receptors, Antigen, T-Cell/immunology Retroviridae Proteins/immunology T-Lymphocytes/classification,immunology Viral Envelope Proteins/immunology
Chemicals
Antibodies, Monoclonal Antigens, Differentiation, T-Lymphocyte CD3 Complex CD8 Antigens Gene Products, gag Receptors, Antigen, T-Cell Retroviridae Proteins Viral Envelope Proteins
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Riviere Y
Viral Oncology Unit, Institut Pasteur, Paris, France.
Tanneau-Salvadori F
Regnault A
Lopez O
Sansonetti P
Guy B
Kieny M P
Fournel J J
Montagnier L
References (41)
41 references, click to expand
  1. Tumour prevention and rejection with recombinant vaccinia.
    Nature. 1987 Apr 30-May 6;326(6116):878-80 PMID: 3033512
  2. Improved antigenicity of the HIV env protein by cleavage site removal.
    Protein Eng. 1988 Sep;2(3):219-25 PMID: 3237686
  3. Pathogenesis of infection with human immunodeficiency virus.
    N Engl J Med. 1987 Jul 30;317(5):278-86 PMID: 3299092
  4. HIV-specific cytotoxic T lymphocytes in seropositive individuals.
    Nature. 1987 Jul 23-29;328(6128):345-8 PMID: 3496541
  5. Lymphocytic choriomeningitis virus: pathogenesis of acute central nervous system disease.
    Fed Proc. 1971 Nov-Dec;30(6):1831-41 PMID: 4942053
  6. Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers.
    J Exp Med. 1972 Apr 1;135(4):874-89 PMID: 4622913
  7. Most influenza A virus-specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants.
    J Exp Med. 1984 Feb 1;159(2):365-77 PMID: 6198430
  8. Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells.
    Cell. 1984 Nov;39(1):13-25 PMID: 6091906
  9. Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection.
    Nature. 1984 Nov 22-28;312(5992):369-71 PMID: 6095095
  10. Nucleotide sequence of the AIDS virus, LAV.
    Cell. 1985 Jan;40(1):9-17 PMID: 2981635
  11. Lymphadenopathy associated virus: its role in the pathogenesis of AIDS and related diseases.
    Prog Allergy. 1986;37:46-64 PMID: 3515354
  12. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    J Immunol. 1986 May 15;136(10):3619-24 PMID: 2422259
  13. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.
    J Immunol. 1986 Jun 15;136(12):4669-73 PMID: 2423598
  14. Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts.
    J Exp Med. 1986 Jul 1;164(1):180-95 PMID: 3014033
  15. Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities.
    J Exp Med. 1986 Jul 1;164(1):211-26 PMID: 2425028
  16. Isolation of a new human retrovirus from West African patients with AIDS.
    Science. 1986 Jul 18;233(4761):343-6 PMID: 2425430
  17. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.
    Cell. 1986 Sep 12;46(6):807-17 PMID: 3638988
  18. N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells.
    J Virol. 1986 Nov;60(2):708-17 PMID: 3022003
  19. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV.
    Science. 1986 Nov 28;234(4780):1123-7 PMID: 3095925
  20. Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants.
    J Immunol. 1986 Dec 15;137(12):3973-7 PMID: 2431051
  21. Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo.
    Cell. 1987 Jan 30;48(2):231-40 PMID: 3026637
  22. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    J Immunol. 1987 Feb 15;138(4):1064-7 PMID: 3027168
  23. Anti-influenza virus cytotoxic T lymphocytes recognize the three viral polymerases and a nonstructural protein: responsiveness to individual viral antigens is major histocompatibility complex controlled.
    J Virol. 1987 Apr;61(4):1098-102 PMID: 3493353
  24. Genome organization and transactivation of the human immunodeficiency virus type 2.
    Nature. 1987 Apr 16-22;326(6114):662-9 PMID: 3031510
  25. AIDS virus-specific cytotoxic T lymphocytes in lung disorders.
    Nature. 1987 Jul 23-29;328(6128):348-51 PMID: 3496542
  26. HSV-1-infected oral epithelial cells are targets for natural killer cells.
    J Dent Res. 1987 Mar;66(3):770-3 PMID: 2440924
  27. The HIV 'A' (sor) gene product is essential for virus infectivity.
    Nature. 1987 Aug 20-26;328(6132):728-30 PMID: 2441266
  28. The sor gene of HIV-1 is required for efficient virus transmission in vitro.
    Science. 1987 Aug 21;237(4817):888-93 PMID: 3497453
  29. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
    J Immunol. 1987 Oct 1;139(7):2263-7 PMID: 3498755
  30. HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product.
    Nature. 1987 Nov 19-25;330(6145):266-9 PMID: 3118220
  31. Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus.
    J Virol. 1988 Mar;62(3):687-95 PMID: 2448497
  32. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.
    Science. 1988 Feb 5;239(4840):617-22 PMID: 3277274
  33. Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus.
    Virology. 1988 Feb;162(2):321-7 PMID: 3257596
  34. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals.
    Science. 1988 Apr 1;240(4848):64-6 PMID: 2451288
  35. Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals.
    Lancet. 1988 Apr 23;1(8591):902-5 PMID: 2895830
  36. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.
    AIDS Res Hum Retroviruses. 1987;3(4):409-22 PMID: 2833917
  37. Virus-triggered immune suppression in mice caused by virus-specific cytotoxic T cells.
    J Exp Med. 1988 May 1;167(5):1749-54 PMID: 2966846
  38. Subcellular localization of the human immunodeficiency virus trans-acting art gene product.
    J Virol. 1988 Jul;62(7):2498-501 PMID: 2836628
  39. Human class I MHC-restricted cytotoxic T-lymphocytes specific for human immunodeficiency virus envelope antigens.
    AIDS. 1988 Apr;2(2):113-7 PMID: 2454643
  40. Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients.
    AIDS. 1988 Jun;2(3):179-83 PMID: 3134912
  41. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    J Immunol. 1987 Jul 1;139(1):55-60 PMID: 3584988
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1989-05-00
Pages
2270-7
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC250645
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com